RNA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

Published online before print January 29, 2008
RNA, DOI: 10.1261/rna.821908
 Copyright © 2008 RNA Society
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
rna.821908v1
14/3/524    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Mayer, G.
Right arrow Articles by Blind, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mayer, G.
Right arrow Articles by Blind, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

An RNA molecule that specifically inhibits G-protein-coupled receptor kinase 2 in vitro

Günter Mayer1, Bernhard Wulffen1, Christian Huber2, Jörg Brockmann3, Birgit Flicke4, Lars Neumann4, Doris Hafenbradl4, Bert M. Klebl4, Martin J. Lohse3, Cornelius Krasel3,5, and Michael Blind2

1 Life and Medical Sciences Bonn, Program Unit Chemical Biology, c/o Kekulé-Institute for Organic Chemistry and Biochemistry, University of Bonn, 53121 Bonn, Germany
2 NascaCell Technologies AG, 81377 Munich, Germany
3 Institute of Pharmacology and Toxicology, University of Würzburg, 97078 Würzburg, Germany
4 GPC Biotech, 82152 Martinsried, Germany
5 School of Pharmacy, University of Reading, Whiteknights, Reading RG6 6AJ, United Kingdom

G-protein-coupled receptors are desensitized by a two-step process. In a first step, G-protein-coupled receptor kinases (GRKs) phosphorylate agonist-activated receptors that subsequently bind to a second class of proteins, the arrestins. GRKs can be classified into three subfamilies, which have been implicated in various diseases. The physiological role(s) of GRKs have been difficult to study as selective inhibitors are not available. We have used SELEX (systematic evolution of ligands by exponential enrichment) to develop RNA aptamers that potently and selectively inhibit GRK2. This process has yielded an aptamer, C13, which bound to GRK2 with a high affinity and inhibited GRK2-catalyzed rhodopsin phosphorylation with an IC50 of 4.1 nM. Phosphorylation of rhodopsin catalyzed by GRK5 was also inhibited, albeit with 20-fold lower potency (IC50 of 79 nM). Furthermore, C13 reveals significant specificity, since almost no inhibitory activity was detectable testing it against a panel of 14 other kinases. The aptamer is two orders of magnitude more potent than the best GRK2 inhibitors described previously and shows high selectivity for the GRK family of protein kinases.

Keywords: in vitro selection; SELEX; aptamer; GRK2; kinase inhibitor

Received September 10, 2007 ; accepted December 7, 2007.

Reprint requests to: Günter Mayer, Life and Medical Sciences Bonn, Program Unit Chemical Biology, c/o Kekulé-Institute for Organic Chemistry and Biochemistry, University of Bonn, Gerhard-Domagk-Strasse 1, 53121 Bonn, Germany; e-mail: gmayer{at}uni-bonn.de; fax: +49-228-734809; or Michael Blind, NascaCell Technologies AG, Max-Lebsche-Platz 31, 81377 Munich, Germany; e-mail: m.blind{at}nascacell.de; fax: +49-89-54727222.

Article published online ahead of print. Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.821908.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the RNA Society.